Definitive Contract 75F40122C00176
Award Date
9/27/22
Potential Completion Date
3/31/28
Potential Value
$237K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
923120 - Administration of Public Health Programs
PSC Category
H265 - Equipment And Materials Testing- Medical, Dental, And Veterinary Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Concord, NH 03301, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the New Hampshire Department of Health & Human Services, a U.S. state government entity. The $138,742.86 Firm Fixed Price contract is for New Hampshire MQSA (Mammography Quality Standards Act) Inspections. The contract does not have a set-aside designation. As the state health and human services agency, the New Hampshire Department of Health & Human Services...
The U.S. Food and Drug Administration (FDA) awarded a $262,548.81 firm fixed-price contract to the South Dakota Department of Health (SD DOH) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). This contract, awarded on June 30, 2022, has an ultimate completion date of January 1, 2028. The contract was issued as a sole-source award, as the state government organization is the...
This is a firm fixed price definitive contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the Maine Department of Health and Human Services (Maine DHHS) for the Maine MQSA Inspection Program. The contract has a potential value of $200,563.40 and a completion date of September 29, 2022. There was no set-aside designation applied to this award. As the prime contractor, Maine DHHS will provide products and services to support the Mammography...
This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...
This is a firm-fixed-price definitive federal contract awarded by the Food and Drug Administration (FDA) to the State of North Carolina Department of Health & Human Services (NC DHHS) for $2,531,901.07 to conduct inspections of certified non-federal mammography facilities in North Carolina and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of September 29, 2027. The contract was awarded under a...
The Food and Drug Administration (FDA) awarded a $485,906.49 firm fixed-price contract to the Arkansas Department of Health (ADH) to conduct inspections of certified non-federal mammography facilities in Arkansas. This contract, awarded on August 8, 2022, is part of the Mammography Quality Standards Act (MQSA) and runs through August 1, 2027. The contract was awarded as a sole source award, as ADH is the only organization in Arkansas with the legal authority and experience required to perform...
This is a Definitive Contract awarded by the Food and Drug Administration (FDA) to the New Mexico Environment Department (NMED) for $650,130.35 to provide Mammography Quality Standards Act (MQSA) inspections in New Mexico. The contract is a Firm Fixed Price agreement with a period of performance through January 14, 2028. NMED, a state government agency, has extensive experience conducting regulatory inspections and environmental monitoring services for federal agencies. This contract award,...
This is a $501,949.66 firm fixed price contract awarded by the Food and Drug Administration (FDA) to the Rhode Island Department of Health to conduct inspections of mammography facilities in Rhode Island under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of January 14, 2028. The Rhode Island Department of Health, a U.S. state government entity, will be the prime contractor delivering these inspection services. This contract award is not associated...
This is a $677,630.31 firm-fixed-price definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the Nevada Department of Health and Human Services (Division of Health) for NEVADA MQSA INSPECTIONS (NEW CONTRACT). The contract is not set aside and has a period of performance through June 30, 2022. The Nevada Department of Health and Human Services is a U.S. state government entity that has previously received federal contracts and grants from...
The U.S. Food and Drug Administration (FDA) awarded a $2,482,950.23 Firm Fixed Price contract to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency, to implement the Mammography Quality Standards Act (MQSA). The contract, awarded without any set-aside designation, runs through March 2022 and requires MDLEO to provide specialized regulatory oversight and services to ensure the quality and safety of mammography facilities. As a state...